Loading asset research
NewcelX Ltd. Ordinary Shares
NCELNasdaq · USD · StocksQuote as of · Exchange session not verified$3.30
-2.23%
Today
NCEL
Loading 1D prices…
Market cap
$19.1M
Volume
3.7K
52w high
$24.6052w low
$1.83Company profile
NewcelX Ltd. Ordinary Shares
NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep disorders, Neurodegenerative/ neuroinflammation diseases, and Diabetes Associated Neurological Disorders. It also develops iTOL-102, NCEL-201, NCEL-301, and NCEL-007. NewcelX Ltd. was founded in 2008 and is headquartered in Kloten, Switzerland.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Kloten, United States
Employees
9
Fiscal year end
1231
CIK
1783036
Session & valuation
Open$3.30
Previous close$3.38
Day high$3.32
Day low$3.22
30-day avg. volume10.4K
Outstanding shares4.8M
Diluted EPS$2.16
Latest annual period
P/E (trailing)1.53
P/E (forward)-5.51
Price / book2.19
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| MRKRMarker Therapeutics Inc. Common Stock | $19.2M | $0.00 | — | -$0.79 | -4.17% | Buy |
| CMMBChemomab Therapeutics Ltd. American Depositary Share | $18.9M | $0.00 | — | $0.018 | -0.77% | Buy |
| ALLRAllarity Therapeutics Inc. Common Stock | $19.4M | $320K | -3509.69% | -$0.78 | -2.40% | Hold |
| LPCNLipocine Inc. Common Stock | $18.7M | $2M | -487.18% | -$1.69 | +0.89% | Hold |
| NEUPNeuphoria Therapeutics Inc. Common Stock | $20.2M | $15.6M | -54.62% | -$2.11 | +0.67% | Hold |